CCR8 inhibitors

Details CCR8 inhibitors CCR8 inhibitors

2003-12-23

2008-05-27

Seaman, D. Margaret (Department: 1625)

Organic compounds -- part of the class 532-570 series

Organic compounds

Heterocyclic carbon compounds containing a hetero ring...

C546S192000

Reexamination Certificate

active

07378525

ABSTRACT:
Disclosed are CCR8 inhibitors represented by Structural Formulas (I):The variables in Structural Formula (I) are described herein. Also disclosed are methods of treating a subject with a CCR8 mediated condition, especially asthma, by administering one of the disclosed CCR8 inhibitors to the subject.

REFERENCES:
patent: 5281626 (1994-01-01), Oinuma et al.
patent: 5354904 (1994-10-01), Mayer et al.
patent: 5378715 (1995-01-01), Stein et al.
patent: 5530118 (1996-06-01), Oinuma et al.
patent: 5571898 (1996-11-01), Schloesser et al.
patent: 5663414 (1997-09-01), Oinuma et al.
patent: 5994398 (1999-11-01), John et al.
patent: 6262112 (2001-07-01), Mittendorf et al.
patent: 6417181 (2002-07-01), Bender et al.
patent: 2003/0130287 (2003-07-01), Ackermann et al.
patent: 2005/0085518 (2005-04-01), Dai et al.
patent: 858 551 (1952-12-01), None
patent: 100 00 739 (2001-07-01), None
patent: 100 53 796 (2002-05-01), None
patent: 0 618 223 (1994-10-01), None
patent: 1 038 868 (2000-09-01), None
patent: 32002219 (1957-04-01), None
patent: 32005169 (1957-07-01), None
patent: 32008075 (1957-09-01), None
patent: 32008422 (1957-09-01), None
patent: 32009570 (1957-11-01), None
patent: 33007538 (1958-08-01), None
patent: 63017870 (1988-01-01), None
patent: 63208042 (1988-08-01), None
patent: 2051146 (1995-12-01), None
patent: 2051147 (1995-12-01), None
patent: 2053226 (1996-01-01), None
patent: 402606 (2000-08-01), None
patent: WO 99/29670 (1990-06-01), None
patent: WO 91/12237 (1991-08-01), None
patent: WO 95/26957 (1995-10-01), None
patent: WO 96/40641 (1996-12-01), None
patent: WO 97/20822 (1997-06-01), None
patent: WO 99/37609 (1999-07-01), None
patent: WO 99/62885 (1999-12-01), None
patent: WO 01/07403 (2001-02-01), None
patent: WO 01/58484 (2001-08-01), None
patent: WO 02/072549 (2002-09-01), None
patent: WO 2006/107252 (2006-10-01), None
patent: WO 2006/107253 (2006-10-01), None
patent: WO 2006/107254 (2006-10-01), None
patent: WO 2007/030061 (2007-03-01), None
Campos et al., J. Org. Chem., 2005, 70, 268-274.
Trushkin, et al., “ANSA-analysis. II. Aminonaphthalenesulfonamides as detectable groups for polysubstrate analysis of proteases,”Biokhimiya(Moscow) 59(10): 1521-1534 (1994).
Nedospasov, A. A., et al., “The Synthesis of N(S)-alkoxyethyl-substituted aminoaphthalenesulfonamides by opening an aziridene ring,”Synlett(8): 661-662 (1992).
Horstmann, H., et al., “Compounds With Schistosomicide Activity. 1. N4-(N-acyl-N-alkylglycyl)sulfanilamide,”European J. Of Medicinal Chem., 12(4): 387-392 (1977).
Database Chemcats ′Online!, Chemical Abstracts Service, Columbus, Ohio, US; XP002280062, Order No. 5242677, 5242739, 5242752 & “Chembridge Product List” Jan. 17, 2002, Chembridge Corporation, 16981 Via Tazon, Suite G, San Diego, CA 92127, USA.
Database Chemcats ′Online!, Chemical Abstracts Service, Columbus, Ohio, US; XP002280063, Order No. BAS 0371287 & Interchim Intermediates, Jul. 9, 2002, Interchim, 213 Avenue Kennedy, BP 1140, Montlucon, Cedex, 03103, France.
Jenkins, Tracy J., et al., “Design, synthesis, and evaluation of naphthalene-sulfonamide antagonists of human CCR8,”Journal of Medicinal Chemistry, vol. 50, No. 3 (2007) pp. 566-584.
Jin, Jian, et al., “Oxazolidinones as novel human CCR8 antagonists,”Bioorganic&Medicinal Chemistry Letters, vol. 17 (2007) pp. 1722-1725.

Affiliated with

Also associated with

Rating

CCR8 inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with CCR8 inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and CCR8 inhibitors will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3983555